OS9 anticorps (AA 353-612)
Aperçu rapide pour OS9 anticorps (AA 353-612) (ABIN6145063)
Antigène
Voir toutes OS9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 353-612
-
Séquence
- NVQVKVIRSP ADLIRFIEEL KGGTKKGKPN IGQEQPVDDA AEVPQREPEK ERGDPERQRE MEEEEDEDED EDEDEDERQL LGEFEKELEG ILLPSDRDRL RSEVKAGMER ELENIIQETE KELDPDGLKK ESERDRAMLA LTSTLNKLIK RLEEKQSPEL VKKHKKKRVV PKKPPPSPQP TGKIEIKIVR PWAEGTEEGA RWLTDEDTRN LKEIFFNILV PGAEEAQKER QRQKELESNY RRVWGSPGGE GTGDLDEFDF
-
Réactivité croisée
- Humain, Souris
-
Attributs du produit
- Polyclonal Antibodies
-
Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 353-612 of human OS9 (NP_001017956.1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB,1:500 - 1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))
-
Autre désignation
- OS9
-
Sujet
- This gene encodes a protein that is highly expressed in osteosarcomas. This protein binds to the hypoxia-inducible factor 1 (HIF-1), a key regulator of the hypoxic response and angiogenesis, and promotes the degradation of one of its subunits. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.,OS9,ERLEC2,OS-9,Epigenetics & Nuclear Signaling,Cancer,Invasion and Metastasis,Endocrine & Metabolism,Cardiovascular,Hypoxia,Hypoxia-related proteins,OS9
-
Poids moléculaire
- 60 kDa/63 kDa/65 kDa/67 kDa/69 kDa/73 kDa/75 kDa
-
ID gène
- 10956
-
UniProt
- Q13438
-
Pathways
- Maintenance of Protein Location, SARS-CoV-2 Protein Interactome
Antigène
-